pyridostigmine bromide has been researched along with Autonomic Dysfunction, Paraneoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K | 1 |
| Aysal, F; Baybas, S; Kucukoglu, H; Ozturk, M; Selçuk, HH; Sozmen, V; Urer, NH | 1 |
1 review(s) available for pyridostigmine bromide and Autonomic Dysfunction, Paraneoplastic
| Article | Year |
|---|---|
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia | 2012 |
1 other study(ies) available for pyridostigmine bromide and Autonomic Dysfunction, Paraneoplastic
| Article | Year |
|---|---|
Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: three years follow up.
Topics: Anticonvulsants; Cholinesterase Inhibitors; Electroencephalography; Follow-Up Studies; Levetiracetam; Magnetic Resonance Imaging; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Piracetam; Pyridostigmine Bromide; Seizures; Thymectomy; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |